CHI Advisors’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $13.5M | Hold |
3,414,468
| – | – | 5.35% | 6 |
|
|
2023
Q2 | $8.72M | Buy |
3,414,468
+668,203
| +24% | +$1.71M | 2.65% | 9 |
|
|
2023
Q1 | $12.4M | Sell |
2,746,265
-727,101
| -21% | -$3.29M | 3.3% | 6 |
|
|
2022
Q4 | $14.3M | Buy |
3,473,366
+58,218
| +2% | +$240K | 3.82% | 6 |
|
|
2022
Q3 | $10.9M | Buy |
3,415,148
+1,900,000
| +125% | +$6.08M | 2.94% | 7 |
|
|
2022
Q2 | $2.97M | Hold |
1,515,148
| – | – | 1.13% | 19 |
|
|
2022
Q1 | $6.14M | Hold |
1,515,148
| – | – | 2.61% | 8 |
|
|
2021
Q4 | $16.3M | Hold |
1,515,148
| – | – | 5.43% | 5 |
|
|
2021
Q3 | $17.5M | Hold |
1,515,148
| – | – | 5.1% | 7 |
|
|
2021
Q2 | $14.9M | Hold |
1,515,148
| – | – | 3.46% | 9 |
|
|
2021
Q1 | $22.1M | Hold |
1,515,148
| – | – | 4.43% | 9 |
|
|
2020
Q4 | $32.4M | Hold |
1,515,148
| – | – | 9.14% | 4 |
|
|
2020
Q3 | $23M | Hold |
1,515,148
| – | – | 8.18% | 4 |
|
|
2020
Q2 | $19.5M | Buy |
+1,515,148
| New | +$19.5M | 7.6% | 5 |
|